0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmacokinetic Service Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-4C11988
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmacokinetic Service Market Research Report 2022
BUY CHAPTERS

Global Pharmacokinetic Service Market Research Report 2025

Code: QYRE-Auto-4C11988
Report
January 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharmacokinetic Service Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pharmacokinetic Service Market

Pharmacokinetic Service Market

The global market for Pharmacokinetic Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Pharmacokinetic service refers to a specialized area of pharmacy practice that focuses on the study of how drugs are absorbed, distributed, metabolized, and eliminated by the body. Pharmacokinetics involves understanding the movement of drugs within the body, including factors such as drug absorption, bioavailability, distribution to different tissues, metabolism by enzymes, and elimination through various routes such as urine or feces.
Pharmacokinetic services are typically provided by pharmacists who have received additional training in this field. These services involve assessing and optimizing drug therapy based on individual patient characteristics, such as age, weight, organ function, and genetic factors. Pharmacokinetic consultations may include drug dosing adjustments, therapeutic drug monitoring, drug-drug interaction assessments, and recommendations for individualized drug regimens.
Pharmacokinetic services are particularly important for drugs with a narrow therapeutic index, where small changes in drug concentrations can significantly impact efficacy and safety. By monitoring drug levels and adjusting dosages accordingly, pharmacokinetic services help to ensure that patients receive the most effective and safe drug therapy.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmacokinetic Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacokinetic Service.
The Pharmacokinetic Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmacokinetic Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmacokinetic Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharmacokinetic Service Market Report

Report Metric Details
Report Name Pharmacokinetic Service Market
CAGR 5%
Segment by Type
  • Pharmacokinetics in vitro (ADME)
  • Pharmacokinetics in vivo (PK)
Segment by Application
  • Enterprise
  • Research Institute
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Creative Biolabs, Cyprotex, Nuventra Pharma Sciences, Viva Biotech, BioPharma, Creative Bioarray, Svar, SAS Medical Center, Creative Animodel, SGS, GenScript ProBio, Research Triangle Institute, Admescope, Proteomics International
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharmacokinetic Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmacokinetic Service Market report?

Ans: The main players in the Pharmacokinetic Service Market are Creative Biolabs, Cyprotex, Nuventra Pharma Sciences, Viva Biotech, BioPharma, Creative Bioarray, Svar, SAS Medical Center, Creative Animodel, SGS, GenScript ProBio, Research Triangle Institute, Admescope, Proteomics International

What are the Application segmentation covered in the Pharmacokinetic Service Market report?

Ans: The Applications covered in the Pharmacokinetic Service Market report are Enterprise, Research Institute

What are the Type segmentation covered in the Pharmacokinetic Service Market report?

Ans: The Types covered in the Pharmacokinetic Service Market report are Pharmacokinetics in vitro (ADME), Pharmacokinetics in vivo (PK)

Recommended Reports

Pharma Services

Drug Testing & Monitoring

Pharmaceutical Logistics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacokinetic Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Pharmacokinetics in vitro (ADME)
1.2.3 Pharmacokinetics in vivo (PK)
1.3 Market by Application
1.3.1 Global Pharmacokinetic Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Enterprise
1.3.3 Research Institute
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacokinetic Service Market Perspective (2020-2031)
2.2 Global Pharmacokinetic Service Growth Trends by Region
2.2.1 Global Pharmacokinetic Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmacokinetic Service Historic Market Size by Region (2020-2025)
2.2.3 Pharmacokinetic Service Forecasted Market Size by Region (2026-2031)
2.3 Pharmacokinetic Service Market Dynamics
2.3.1 Pharmacokinetic Service Industry Trends
2.3.2 Pharmacokinetic Service Market Drivers
2.3.3 Pharmacokinetic Service Market Challenges
2.3.4 Pharmacokinetic Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacokinetic Service Players by Revenue
3.1.1 Global Top Pharmacokinetic Service Players by Revenue (2020-2025)
3.1.2 Global Pharmacokinetic Service Revenue Market Share by Players (2020-2025)
3.2 Global Pharmacokinetic Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmacokinetic Service Revenue
3.4 Global Pharmacokinetic Service Market Concentration Ratio
3.4.1 Global Pharmacokinetic Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacokinetic Service Revenue in 2024
3.5 Global Key Players of Pharmacokinetic Service Head office and Area Served
3.6 Global Key Players of Pharmacokinetic Service, Product and Application
3.7 Global Key Players of Pharmacokinetic Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacokinetic Service Breakdown Data by Type
4.1 Global Pharmacokinetic Service Historic Market Size by Type (2020-2025)
4.2 Global Pharmacokinetic Service Forecasted Market Size by Type (2026-2031)
5 Pharmacokinetic Service Breakdown Data by Application
5.1 Global Pharmacokinetic Service Historic Market Size by Application (2020-2025)
5.2 Global Pharmacokinetic Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmacokinetic Service Market Size (2020-2031)
6.2 North America Pharmacokinetic Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmacokinetic Service Market Size by Country (2020-2025)
6.4 North America Pharmacokinetic Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmacokinetic Service Market Size (2020-2031)
7.2 Europe Pharmacokinetic Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmacokinetic Service Market Size by Country (2020-2025)
7.4 Europe Pharmacokinetic Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacokinetic Service Market Size (2020-2031)
8.2 Asia-Pacific Pharmacokinetic Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmacokinetic Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmacokinetic Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmacokinetic Service Market Size (2020-2031)
9.2 Latin America Pharmacokinetic Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmacokinetic Service Market Size by Country (2020-2025)
9.4 Latin America Pharmacokinetic Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacokinetic Service Market Size (2020-2031)
10.2 Middle East & Africa Pharmacokinetic Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmacokinetic Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmacokinetic Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Biolabs
11.1.1 Creative Biolabs Company Details
11.1.2 Creative Biolabs Business Overview
11.1.3 Creative Biolabs Pharmacokinetic Service Introduction
11.1.4 Creative Biolabs Revenue in Pharmacokinetic Service Business (2020-2025)
11.1.5 Creative Biolabs Recent Development
11.2 Cyprotex
11.2.1 Cyprotex Company Details
11.2.2 Cyprotex Business Overview
11.2.3 Cyprotex Pharmacokinetic Service Introduction
11.2.4 Cyprotex Revenue in Pharmacokinetic Service Business (2020-2025)
11.2.5 Cyprotex Recent Development
11.3 Nuventra Pharma Sciences
11.3.1 Nuventra Pharma Sciences Company Details
11.3.2 Nuventra Pharma Sciences Business Overview
11.3.3 Nuventra Pharma Sciences Pharmacokinetic Service Introduction
11.3.4 Nuventra Pharma Sciences Revenue in Pharmacokinetic Service Business (2020-2025)
11.3.5 Nuventra Pharma Sciences Recent Development
11.4 Viva Biotech
11.4.1 Viva Biotech Company Details
11.4.2 Viva Biotech Business Overview
11.4.3 Viva Biotech Pharmacokinetic Service Introduction
11.4.4 Viva Biotech Revenue in Pharmacokinetic Service Business (2020-2025)
11.4.5 Viva Biotech Recent Development
11.5 BioPharma
11.5.1 BioPharma Company Details
11.5.2 BioPharma Business Overview
11.5.3 BioPharma Pharmacokinetic Service Introduction
11.5.4 BioPharma Revenue in Pharmacokinetic Service Business (2020-2025)
11.5.5 BioPharma Recent Development
11.6 Creative Bioarray
11.6.1 Creative Bioarray Company Details
11.6.2 Creative Bioarray Business Overview
11.6.3 Creative Bioarray Pharmacokinetic Service Introduction
11.6.4 Creative Bioarray Revenue in Pharmacokinetic Service Business (2020-2025)
11.6.5 Creative Bioarray Recent Development
11.7 Svar
11.7.1 Svar Company Details
11.7.2 Svar Business Overview
11.7.3 Svar Pharmacokinetic Service Introduction
11.7.4 Svar Revenue in Pharmacokinetic Service Business (2020-2025)
11.7.5 Svar Recent Development
11.8 SAS Medical Center
11.8.1 SAS Medical Center Company Details
11.8.2 SAS Medical Center Business Overview
11.8.3 SAS Medical Center Pharmacokinetic Service Introduction
11.8.4 SAS Medical Center Revenue in Pharmacokinetic Service Business (2020-2025)
11.8.5 SAS Medical Center Recent Development
11.9 Creative Animodel
11.9.1 Creative Animodel Company Details
11.9.2 Creative Animodel Business Overview
11.9.3 Creative Animodel Pharmacokinetic Service Introduction
11.9.4 Creative Animodel Revenue in Pharmacokinetic Service Business (2020-2025)
11.9.5 Creative Animodel Recent Development
11.10 SGS
11.10.1 SGS Company Details
11.10.2 SGS Business Overview
11.10.3 SGS Pharmacokinetic Service Introduction
11.10.4 SGS Revenue in Pharmacokinetic Service Business (2020-2025)
11.10.5 SGS Recent Development
11.11 GenScript ProBio
11.11.1 GenScript ProBio Company Details
11.11.2 GenScript ProBio Business Overview
11.11.3 GenScript ProBio Pharmacokinetic Service Introduction
11.11.4 GenScript ProBio Revenue in Pharmacokinetic Service Business (2020-2025)
11.11.5 GenScript ProBio Recent Development
11.12 Research Triangle Institute
11.12.1 Research Triangle Institute Company Details
11.12.2 Research Triangle Institute Business Overview
11.12.3 Research Triangle Institute Pharmacokinetic Service Introduction
11.12.4 Research Triangle Institute Revenue in Pharmacokinetic Service Business (2020-2025)
11.12.5 Research Triangle Institute Recent Development
11.13 Admescope
11.13.1 Admescope Company Details
11.13.2 Admescope Business Overview
11.13.3 Admescope Pharmacokinetic Service Introduction
11.13.4 Admescope Revenue in Pharmacokinetic Service Business (2020-2025)
11.13.5 Admescope Recent Development
11.14 Proteomics International
11.14.1 Proteomics International Company Details
11.14.2 Proteomics International Business Overview
11.14.3 Proteomics International Pharmacokinetic Service Introduction
11.14.4 Proteomics International Revenue in Pharmacokinetic Service Business (2020-2025)
11.14.5 Proteomics International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Pharmacokinetic Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Pharmacokinetics in vitro (ADME)
 Table 3. Key Players of Pharmacokinetics in vivo (PK)
 Table 4. Global Pharmacokinetic Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Pharmacokinetic Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pharmacokinetic Service Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Pharmacokinetic Service Market Share by Region (2020-2025)
 Table 8. Global Pharmacokinetic Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Pharmacokinetic Service Market Share by Region (2026-2031)
 Table 10. Pharmacokinetic Service Market Trends
 Table 11. Pharmacokinetic Service Market Drivers
 Table 12. Pharmacokinetic Service Market Challenges
 Table 13. Pharmacokinetic Service Market Restraints
 Table 14. Global Pharmacokinetic Service Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Pharmacokinetic Service Market Share by Players (2020-2025)
 Table 16. Global Top Pharmacokinetic Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacokinetic Service as of 2024)
 Table 17. Ranking of Global Top Pharmacokinetic Service Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Pharmacokinetic Service Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Pharmacokinetic Service, Headquarters and Area Served
 Table 20. Global Key Players of Pharmacokinetic Service, Product and Application
 Table 21. Global Key Players of Pharmacokinetic Service, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Pharmacokinetic Service Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Pharmacokinetic Service Revenue Market Share by Type (2020-2025)
 Table 25. Global Pharmacokinetic Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Pharmacokinetic Service Revenue Market Share by Type (2026-2031)
 Table 27. Global Pharmacokinetic Service Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Pharmacokinetic Service Revenue Market Share by Application (2020-2025)
 Table 29. Global Pharmacokinetic Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Pharmacokinetic Service Revenue Market Share by Application (2026-2031)
 Table 31. North America Pharmacokinetic Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Pharmacokinetic Service Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Pharmacokinetic Service Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Pharmacokinetic Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Pharmacokinetic Service Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Pharmacokinetic Service Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Pharmacokinetic Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Pharmacokinetic Service Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Pharmacokinetic Service Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pharmacokinetic Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Pharmacokinetic Service Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Pharmacokinetic Service Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Pharmacokinetic Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Pharmacokinetic Service Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Pharmacokinetic Service Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Creative Biolabs Company Details
 Table 47. Creative Biolabs Business Overview
 Table 48. Creative Biolabs Pharmacokinetic Service Product
 Table 49. Creative Biolabs Revenue in Pharmacokinetic Service Business (2020-2025) & (US$ Million)
 Table 50. Creative Biolabs Recent Development
 Table 51. Cyprotex Company Details
 Table 52. Cyprotex Business Overview
 Table 53. Cyprotex Pharmacokinetic Service Product
 Table 54. Cyprotex Revenue in Pharmacokinetic Service Business (2020-2025) & (US$ Million)
 Table 55. Cyprotex Recent Development
 Table 56. Nuventra Pharma Sciences Company Details
 Table 57. Nuventra Pharma Sciences Business Overview
 Table 58. Nuventra Pharma Sciences Pharmacokinetic Service Product
 Table 59. Nuventra Pharma Sciences Revenue in Pharmacokinetic Service Business (2020-2025) & (US$ Million)
 Table 60. Nuventra Pharma Sciences Recent Development
 Table 61. Viva Biotech Company Details
 Table 62. Viva Biotech Business Overview
 Table 63. Viva Biotech Pharmacokinetic Service Product
 Table 64. Viva Biotech Revenue in Pharmacokinetic Service Business (2020-2025) & (US$ Million)
 Table 65. Viva Biotech Recent Development
 Table 66. BioPharma Company Details
 Table 67. BioPharma Business Overview
 Table 68. BioPharma Pharmacokinetic Service Product
 Table 69. BioPharma Revenue in Pharmacokinetic Service Business (2020-2025) & (US$ Million)
 Table 70. BioPharma Recent Development
 Table 71. Creative Bioarray Company Details
 Table 72. Creative Bioarray Business Overview
 Table 73. Creative Bioarray Pharmacokinetic Service Product
 Table 74. Creative Bioarray Revenue in Pharmacokinetic Service Business (2020-2025) & (US$ Million)
 Table 75. Creative Bioarray Recent Development
 Table 76. Svar Company Details
 Table 77. Svar Business Overview
 Table 78. Svar Pharmacokinetic Service Product
 Table 79. Svar Revenue in Pharmacokinetic Service Business (2020-2025) & (US$ Million)
 Table 80. Svar Recent Development
 Table 81. SAS Medical Center Company Details
 Table 82. SAS Medical Center Business Overview
 Table 83. SAS Medical Center Pharmacokinetic Service Product
 Table 84. SAS Medical Center Revenue in Pharmacokinetic Service Business (2020-2025) & (US$ Million)
 Table 85. SAS Medical Center Recent Development
 Table 86. Creative Animodel Company Details
 Table 87. Creative Animodel Business Overview
 Table 88. Creative Animodel Pharmacokinetic Service Product
 Table 89. Creative Animodel Revenue in Pharmacokinetic Service Business (2020-2025) & (US$ Million)
 Table 90. Creative Animodel Recent Development
 Table 91. SGS Company Details
 Table 92. SGS Business Overview
 Table 93. SGS Pharmacokinetic Service Product
 Table 94. SGS Revenue in Pharmacokinetic Service Business (2020-2025) & (US$ Million)
 Table 95. SGS Recent Development
 Table 96. GenScript ProBio Company Details
 Table 97. GenScript ProBio Business Overview
 Table 98. GenScript ProBio Pharmacokinetic Service Product
 Table 99. GenScript ProBio Revenue in Pharmacokinetic Service Business (2020-2025) & (US$ Million)
 Table 100. GenScript ProBio Recent Development
 Table 101. Research Triangle Institute Company Details
 Table 102. Research Triangle Institute Business Overview
 Table 103. Research Triangle Institute Pharmacokinetic Service Product
 Table 104. Research Triangle Institute Revenue in Pharmacokinetic Service Business (2020-2025) & (US$ Million)
 Table 105. Research Triangle Institute Recent Development
 Table 106. Admescope Company Details
 Table 107. Admescope Business Overview
 Table 108. Admescope Pharmacokinetic Service Product
 Table 109. Admescope Revenue in Pharmacokinetic Service Business (2020-2025) & (US$ Million)
 Table 110. Admescope Recent Development
 Table 111. Proteomics International Company Details
 Table 112. Proteomics International Business Overview
 Table 113. Proteomics International Pharmacokinetic Service Product
 Table 114. Proteomics International Revenue in Pharmacokinetic Service Business (2020-2025) & (US$ Million)
 Table 115. Proteomics International Recent Development
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources
 Table 119. Authors List of This Report


List of Figures
 Figure 1. Pharmacokinetic Service Picture
 Figure 2. Global Pharmacokinetic Service Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharmacokinetic Service Market Share by Type: 2024 VS 2031
 Figure 4. Pharmacokinetics in vitro (ADME) Features
 Figure 5. Pharmacokinetics in vivo (PK) Features
 Figure 6. Global Pharmacokinetic Service Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pharmacokinetic Service Market Share by Application: 2024 VS 2031
 Figure 8. Enterprise Case Studies
 Figure 9. Research Institute Case Studies
 Figure 10. Pharmacokinetic Service Report Years Considered
 Figure 11. Global Pharmacokinetic Service Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Pharmacokinetic Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Pharmacokinetic Service Market Share by Region: 2024 VS 2031
 Figure 14. Global Pharmacokinetic Service Market Share by Players in 2024
 Figure 15. Global Top Pharmacokinetic Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacokinetic Service as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Pharmacokinetic Service Revenue in 2024
 Figure 17. North America Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Pharmacokinetic Service Market Share by Country (2020-2031)
 Figure 19. United States Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Pharmacokinetic Service Market Share by Country (2020-2031)
 Figure 23. Germany Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Pharmacokinetic Service Market Share by Region (2020-2031)
 Figure 31. China Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Pharmacokinetic Service Market Share by Country (2020-2031)
 Figure 39. Mexico Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Pharmacokinetic Service Market Share by Country (2020-2031)
 Figure 43. Turkey Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Pharmacokinetic Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Creative Biolabs Revenue Growth Rate in Pharmacokinetic Service Business (2020-2025)
 Figure 47. Cyprotex Revenue Growth Rate in Pharmacokinetic Service Business (2020-2025)
 Figure 48. Nuventra Pharma Sciences Revenue Growth Rate in Pharmacokinetic Service Business (2020-2025)
 Figure 49. Viva Biotech Revenue Growth Rate in Pharmacokinetic Service Business (2020-2025)
 Figure 50. BioPharma Revenue Growth Rate in Pharmacokinetic Service Business (2020-2025)
 Figure 51. Creative Bioarray Revenue Growth Rate in Pharmacokinetic Service Business (2020-2025)
 Figure 52. Svar Revenue Growth Rate in Pharmacokinetic Service Business (2020-2025)
 Figure 53. SAS Medical Center Revenue Growth Rate in Pharmacokinetic Service Business (2020-2025)
 Figure 54. Creative Animodel Revenue Growth Rate in Pharmacokinetic Service Business (2020-2025)
 Figure 55. SGS Revenue Growth Rate in Pharmacokinetic Service Business (2020-2025)
 Figure 56. GenScript ProBio Revenue Growth Rate in Pharmacokinetic Service Business (2020-2025)
 Figure 57. Research Triangle Institute Revenue Growth Rate in Pharmacokinetic Service Business (2020-2025)
 Figure 58. Admescope Revenue Growth Rate in Pharmacokinetic Service Business (2020-2025)
 Figure 59. Proteomics International Revenue Growth Rate in Pharmacokinetic Service Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart